vatalanib has been researched along with isogranulatimide in 1 studies
| Studies (vatalanib) | Trials (vatalanib) | Recent Studies (post-2010) (vatalanib) | Studies (isogranulatimide) | Trials (isogranulatimide) | Recent Studies (post-2010) (isogranulatimide) |
|---|---|---|---|---|---|
| 276 | 42 | 98 | 19 | 0 | 7 |
| Protein | Taxonomy | vatalanib (IC50) | isogranulatimide (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase Chk1 | Homo sapiens (human) | 0.27 | |
| Serine/threonine-protein kinase Chk2 | Homo sapiens (human) | 3 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 10 | |
| Interferon-induced, double-stranded RNA-activated protein kinase | Homo sapiens (human) | 0.1 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.5 | |
| DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
1 other study(ies) available for vatalanib and isogranulatimide
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |